Cargando…

Metabolic Rewiring in the Tumor Microenvironment to Support Immunotherapy: A Focus on Neutrophils, Polymorphonuclear Myeloid-Derived Suppressor Cells and Natural Killer Cells

Leukocytes often undergo rapid changes in cell phenotype, for example, from a resting to an activated state, which places significant metabolic demands on the cell. These rapid changes in metabolic demand need to be tightly regulated to support immune cell effector functions during the initiation an...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Lerma Barbaro, Andrea, Palano, Maria Teresa, Cucchiara, Martina, Gallazzi, Matteo, Mortara, Lorenzo, Bruno, Antonino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539473/ https://www.ncbi.nlm.nih.gov/pubmed/34696286 http://dx.doi.org/10.3390/vaccines9101178

Ejemplares similares

Neutrophil and Natural Killer Cell Interactions in Cancers: Dangerous Liaisons Instructing Immunosuppression and Angiogenesis
por: Palano, Maria Teresa, et al.
Publicado: (2021)

Role of Polymorphonuclear Myeloid‐Derived Suppressor Cells and Neutrophils in Ischemic Stroke
por: Yan, Haomin, et al.
Publicado: (2023)

The tumor innate immune microenvironment in prostate cancer: an overview of soluble factors and cellular effectors
por: Palano, Maria Teresa, et al.
Publicado: (2022)

When a Friend Becomes Your Enemy: Natural Killer Cells in Atherosclerosis and Atherosclerosis-Associated Risk Factors
por: Palano, Maria Teresa, et al.
Publicado: (2022)

Neutrophils and polymorphonuclear myeloid-derived suppressor cells: an emerging battleground in cancer therapy
por: Raskov, Hans, et al.
Publicado: (2022)

Natural Killer Cell Interactions With Myeloid Derived Suppressor Cells in the Tumor Microenvironment and Implications for Cancer Immunotherapy
por: Zalfa, Cristina, et al.
Publicado: (2021)

Myeloid Derived Suppressor Cells Interactions With Natural Killer Cells and Pro-angiogenic Activities: Roles in Tumor Progression
por: Bruno, Antonino, et al.
Publicado: (2019)

Analysis of classical neutrophils and polymorphonuclear myeloid-derived suppressor cells in cancer patients and tumor-bearing mice
por: Veglia, Filippo, et al.
Publicado: (2021)

Expansion of Polymorphonuclear Myeloid-Derived Suppressor Cells in Patients With Gout
por: Zhong, Limei, et al.
Publicado: (2020)

A new histone deacetylase inhibitor remodels the tumor microenvironment by deletion of polymorphonuclear myeloid-derived suppressor cells and sensitizes prostate cancer to immunotherapy
por: Chen, Zude, et al.
Publicado: (2023)

Neutrophils’ Contribution to Periodontitis and Periodontitis-Associated Cardiovascular Diseases
por: Bassani, Barbara, et al.
Publicado: (2023)

Polymorphonuclear Myeloid-Derived Suppressor Cells Are Abundant in Peripheral Blood of Cancer Patients and Suppress Natural Killer Cell Anti-Tumor Activity
por: Tumino, Nicola, et al.
Publicado: (2022)

CD115(−) monocytic myeloid-derived suppressor cells are precursors of OLFM4(high) polymorphonuclear myeloid-derived suppressor cells
por: Zou, Yunyun, et al.
Publicado: (2023)

Targeting myeloid-derived suppressor cells to enhance natural killer cell-based immunotherapy
por: Joshi, Shweta, et al.
Publicado: (2022)

Immunotherapy Targeting Myeloid-Derived Suppressor Cells (MDSCs) in Tumor Microenvironment
por: Gao, Xidan, et al.
Publicado: (2021)

Blocking Migration of Polymorphonuclear Myeloid-Derived Suppressor Cells Inhibits Mouse Melanoma Progression
por: Groth, Christopher, et al.
Publicado: (2021)

Natural Killer Cells as Key Players of Tumor Progression and Angiogenesis: Old and Novel Tools to Divert Their Pro-Tumor Activities into Potent Anti-Tumor Effects
por: Bassani, Barbara, et al.
Publicado: (2019)

A Novel DNA Aptamer for Dual Targeting of Polymorphonuclear Myeloid-derived Suppressor Cells and Tumor Cells
por: Liu, Haoran, et al.
Publicado: (2018)

Increase in polymorphonuclear myeloid-derived suppressor cells and regulatory T-cells in children with B-cell acute lymphoblastic leukemia
por: Zahran, Asmaa M., et al.
Publicado: (2021)

Immunosenescence of Polymorphonuclear Neutrophils
por: Wessels, Inga, et al.
Publicado: (2010)

Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy
por: Gaggero, Silvia, et al.
Publicado: (2021)

A new procedure to analyze polymorphonuclear myeloid derived suppressor cells in cryopreserved samples cells by flow cytometry
por: Sacchi, Alessandra, et al.
Publicado: (2018)

CCL2 Promotes Colorectal Carcinogenesis by Enhancing Polymorphonuclear Myeloid-Derived Suppressor Cell Population and Function
por: Chun, Eunyoung, et al.
Publicado: (2015)

Temporal and spatial profile of polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) in ischemic stroke in mice
por: Kawano, Tomohiro, et al.
Publicado: (2019)

Bacterial Killing Activity of Polymorphonuclear Myeloid-Derived Suppressor Cells Isolated From Tumor-Bearing Dogs
por: Hlavaty, Sabina I., et al.
Publicado: (2019)

CD205(+) polymorphonuclear myeloid‐derived suppressor cells suppress antitumor immunity by overexpressing GLUT3
por: Fu, Chenghao, et al.
Publicado: (2021)

Suppressive role of myeloid-derived suppressor cells (MDSCs) in the microenvironment of breast cancer and targeted immunotherapies
por: Shou, Dawei, et al.
Publicado: (2016)

Polymorphonuclear myeloid-derived suppressor cells impair the anti-tumor efficacy of GD2.CAR T-cells in patients with neuroblastoma
por: Tumino, Nicola, et al.
Publicado: (2021)

Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy
por: Albini, Adriana, et al.
Publicado: (2018)

Decreased Polymorphonuclear Myeloid-Derived Suppressor Cells and ROS Production Correlated Closely with Bronchopulmonary Dysplasia in Preterm Infants
por: Liu, Wangkai, et al.
Publicado: (2022)

Continuous renal replacement therapy attenuates polymorphonuclear myeloid-derived suppressor cell expansion in pediatric severe sepsis
por: Feng, Shuyun, et al.
Publicado: (2022)

The activation of polymorphonuclear neutrophils and the complement system during immunotherapy with recombinant interleukin-2.
por: Baars, J. W., et al.
Publicado: (1992)

Myeloid Derived Suppressor Cells (MDSCs) Are Increased and Exert Immunosuppressive Activity Together with Polymorphonuclear Leukocytes (PMNs) in Chronic Myeloid Leukemia Patients
por: Giallongo, Cesarina, et al.
Publicado: (2014)

Intracellular Lipid Accumulation Drives the Differentiation of Decidual Polymorphonuclear Myeloid-Derived Suppressor Cells via Arachidonic Acid Metabolism
por: Wang, Qiaohong, et al.
Publicado: (2022)

ARID1A loss induces polymorphonuclear myeloid-derived suppressor cell chemotaxis and promotes prostate cancer progression
por: Li, Ni, et al.
Publicado: (2022)

Retracted: Decreased Polymorphonuclear Myeloid-Derived Suppressor Cells and ROS Production Correlated Closely with Bronchopulmonary Dysplasia in Preterm Infants
por: Longevity, Oxidative Medicine and Cellular
Publicado: (2023)

Polymorphonuclear myeloid-derived suppressor cells and phosphatidylinositol-3 kinase gamma are critical to tobacco-mimicking oral carcinogenesis in mice
por: Nguyen, Khoa A, et al.
Publicado: (2023)

The Ovarian Cancer Tumor Immune Microenvironment (TIME) as Target for Therapy: A Focus on Innate Immunity Cells as Therapeutic Effectors
por: Baci, Denisa, et al.
Publicado: (2020)

Adipose mesenchymal stem cell-derived soluble factors, produced under hypoxic condition, efficiently support in vivo angiogenesis
por: Barone, Ludovica, et al.
Publicado: (2023)

Targeting Myeloid-Derived Suppressor Cells in Cancer Immunotherapy
por: Wang, Yufei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i0cj3ovggocrcnf98rc9ir8kek